AVIRAtea Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $5.85 (+1.56% today)

Market Cap: $458.91M

P/E (TTM): -2.80

Relative Strength (RS%): 80

-9.3% from 52-week high

CANSLIM: Passes criteria

Back to Scanner

AVIR

NASDAQCANSLIMRS 80Score 39

Atea Pharmaceuticals, Inc.

HealthcareBiotechnology$458.91M5 setups passing
$5.85
+1.6% ($0.09)
-9.3% from 52W High
P/E (TTM)
-2.80
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
0.0%
ROE
-46.3%
D/E
0.00
Div Yield
0.0%
Avg Volume
442.9K

Price Chart

Key Levels

SMA 200
$3.72
SMA 50
$4.93
Price
$5.85
52W High
$6.45

Setup Radar

5/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst